New features of glatiramer acetate for the treatment of remitting multiple sclerosis

The article discusses usage of the new dosage of glatiramer acetate (Copaxone®) for the treatment of relapsing-remitting multiple sclerosis. Results of phase II and III clinical trials are presented. Randomized clinical trials GALA and GLACIER demonstrated high efficacy, good safety and tolerability...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: N. Y. Lasch
Formato: Artigo
Idioma:Russo
Publicado em: Remedium Group LLC 2015-12-01
Colecção:Медицинский совет
Assuntos:
рассеянный склероз
препараты
изменяющие течение рассеянного склероза (питрс)
глатирамера ацетат
multiple sclerosis
multiple sclerosis disease-modifying medications (msdmm)
glatiramer acetate
Acesso em linha:https://www.med-sovet.pro/jour/article/view/273
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados